Serum gets DCGI nod for Phase 2 & 3 trials

-
Serum gets DCGI nod for Phase 2 & 3 trials
India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.

from Times of India https://ift.tt/39ZeN7J
https://ift.tt/eA8V8J
via Blogger https://ift.tt/30pPc4I
August 03, 2020 at 08:56PM

Comments

Post a Comment

Popular posts from this blog

Cash reaches 40% of 20 cr women beneficiaries

-
The largest-ever cash transfer scheme launched on Friday to put Rs 30,000 crore in Jan Dhan accounts of women has validated the push for implementation of the Jan Dhan scheme which saw the govt urged crores of people to open bank accounts. ​​By Saturday, the accounts of around 40% of the 20-cr women beneficiaries had seen cash deposits of Rs 500 each. from Times of India https://ift.tt/2UJElQ4 https://ift.tt/eA8V8J
Read more